Reducing Perinatal Stroke Risk Through Maternal Care

Perinatal stroke refers to a cerebrovascular injury occurring before birth, during labour or in the first 28 days of life. It can result from arterial ischaemic stroke, cerebral sinovenous thrombosis or haemorrhage, and may later present as seizures, feeding difficulty, abnormal tone or an early hand preference. The event is often unexpected, yet maternal health and placental function can influence several pathways linked with fetal and neonatal brain injury.

Prevention therefore begins well before delivery. A careful history, timely treatment of hypertension and infection, appropriate management of diabetes, and clear escalation plans can reduce avoidable risk. For Australian families, care may involve a general practitioner, midwife, obstetrician, maternal-fetal medicine specialist and neonatal team across different services, particularly when pregnancy occurs outside a major city.

Understanding The Preventable Pathways

The fetal brain depends on steady oxygen and blood flow through the placenta. Maternal pre-eclampsia, severe hypertension, placental abruption, clotting disorders and systemic inflammation can interfere with that circulation. Some injuries arise from thrombosis in the placenta or fetal vessels, while others follow hypoxia, haemorrhage or embolic events around birth.

A risk factor does not mean that a stroke will occur, and many cases have no clearly identifiable cause. Prevention is therefore based on risk reduction rather than prediction with certainty. Clinicians should distinguish maternal stroke, which affects the pregnant person, from perinatal stroke, which affects the fetus or newborn. The two may share vascular causes but require different emergency pathways.

The scientific focus of the congress archive included perinatal and neonatal medicine, abstracts and research relevant to this field. The FAOPS 2020 meeting in Tokyo was cancelled in April 2020 because of COVID-19 and international travel restrictions, yet its subject remains important for contemporary maternity and newborn services.

Maternal Conditions That Raise Risk

Hypertensive disorders of pregnancy are among the most important maternal concerns. Chronic hypertension, gestational hypertension and pre-eclampsia can impair placental perfusion and are associated with fetal growth restriction, placental separation and medically indicated preterm birth. Regular blood pressure checks, urine assessment and review of symptoms such as severe headache, visual disturbance or right upper abdominal pain support earlier intervention.

Diabetes, obesity, autoimmune disease and kidney disease can create a more complex vascular environment. Antiphospholipid syndrome and selected inherited thrombophilias may increase clotting risk, although testing and anticoagulation should be guided by a specialist rather than broad screening. Previous venous thrombosis, recurrent pregnancy loss, a strong family history of clotting, or a known autoimmune condition deserves documentation at the first antenatal visit.

Infection and inflammation also matter. Chorioamnionitis, maternal fever, untreated urinary infection and some systemic viral illnesses can affect placental health or trigger premature birth. Australian clinicians should take a practical history covering smoking, vaping, alcohol, recreational drugs, prescribed medicines and access to food, housing and transport. These social factors can determine whether a pregnant person can attend monitoring or fill a prescription as planned.

Assessing Risk Across Australian Care

Australia’s maternity system combines public hospitals, private obstetric care, community midwifery and general practice. Medicare-supported antenatal visits can provide regular surveillance, while private insurance may influence where a patient gives birth. A risk assessment should remain clinically based, with clear referral thresholds rather than assumptions about a family’s location, income or insurance.

Geography can change the safety margin. A pregnant person in regional Western Australia, the Northern Territory or far north Queensland may need telehealth review, planned travel or retrieval coordination to reach a tertiary neonatal intensive care unit. Families in Sydney, Melbourne, Brisbane, Adelaide and Perth may live closer to specialist services, but metropolitan hospitals can still face capacity pressure. The plan should identify where assessment will occur after hours and how urgent transfer will be arranged.

Maternal or placental concern Useful antenatal clues Risk-reduction response
Chronic or gestational hypertension Repeated elevated readings, proteinuria, headache or visual symptoms Home or clinic monitoring, medication review, pre-eclampsia assessment and timely specialist referral
Diabetes or marked metabolic risk High glucose results, excessive fetal growth or vascular disease Nutrition support, glucose monitoring, prescribed treatment and fetal growth surveillance
Antiphospholipid syndrome or previous thrombosis Prior clot, recurrent loss, autoimmune disease or positive specialist testing Haematology or maternal-fetal medicine advice and an individual anticoagulation plan
Infection or intra-amniotic inflammation Fever, uterine tenderness, abnormal discharge or prolonged rupture of membranes Prompt testing, antibiotics when indicated and birth planning with neonatal input
Placental dysfunction or abruption risk Bleeding, pain, growth restriction or abnormal Doppler findings Urgent review, fetal surveillance and a documented escalation pathway
Smoking, vaping, alcohol or drug exposure Disclosure at booking, withdrawal symptoms or social vulnerability Non-judgemental cessation care, safeguarding support and coordinated follow-up

The purpose of this framework is to identify modifiable threats without creating unnecessary alarm. Routine fetal surveillance cannot reliably rule out perinatal stroke, and a normal scan does not remove the need to respond to maternal deterioration. Decisions should reflect gestation, fetal growth, placental findings, maternal stability and the capability of the proposed birth setting.

Turning Evidence Into Antenatal Action

Australia has several practical prevention advantages. Mandatory folic acid fortification of eligible wheat flour under the Australia New Zealand Food Standards Code helps reduce neural tube defects, although folate advice remains important for people planning pregnancy. State and territory smoke-free laws support tobacco control in public places, while cessation services can address smoking in the home, where exposure may continue.

Medication review is another high-value step. Aspirin, antihypertensives, insulin, anticoagulants and antiepileptic medicines may need adjustment before conception or during pregnancy, but stopping treatment without advice can be dangerous. A pharmacist, GP and obstetric team should reconcile prescriptions, over-the-counter products and supplements, with attention to the Therapeutic Goods Administration’s pregnancy safety information.

For families and primary care teams:

  • Record hypertension, diabetes, autoimmune disease and clotting history early.
  • Arrange smoking, vaping, alcohol and drug support without judgement.
  • Confirm warning signs, after-hours contacts and transport arrangements.
  • Review medicines before conception or at the first antenatal visit.

For maternity services:

  • Use consistent escalation criteria for blood pressure and bleeding.
  • Share placental, fetal growth and anticoagulation information across teams.
  • Include neonatal staff when preterm birth or neurological risk is foreseeable.
  • Document the destination hospital and retrieval plan for rural families.

Shared decision-making is particularly important when surveillance identifies growth restriction or placental dysfunction. The discussion should explain the balance between continuing pregnancy and delivering early, including the effects of prematurity on neurological outcomes. Australian patients should receive information in accessible language, with interpreters and culturally safe care where needed.

Coordinating Birth And Newborn Care

Antenatal risk reduction must continue into labour. Severe maternal hypertension, fever, prolonged rupture of membranes, placental abruption and fetal heart-rate abnormalities call for rapid reassessment. The appropriate response may involve antibiotics, magnesium sulfate for selected pre-eclampsia protocols, blood pressure treatment, corticosteroids for anticipated preterm birth or urgent delivery. These interventions are determined by the clinical situation, not by a diagnosis of perinatal stroke.

Mode of birth should be selected for obstetric reasons. Caesarean birth is not a universal prevention strategy for neonatal stroke, and unnecessary operative delivery brings its own risks. When birth is likely to occur preterm or the fetus has significant growth restriction, neonatal consultation can clarify resuscitation, thermal care, respiratory support and transfer arrangements.

After birth, staff should respond promptly to seizures, abnormal consciousness, asymmetric movements, apnoea or feeding difficulty. Neonatal neurological assessment, glucose testing, infection evaluation and brain imaging may be required. Magnetic resonance imaging is often valuable when the infant is stable, while cranial ultrasound can provide an initial bedside assessment in some settings. Treatment depends on the suspected mechanism and may include seizure management, respiratory support and specialist neurology follow-up.

Parents may notice subtle signs after discharge, such as persistent stiffness on one side or an unusual preference for using one hand. Early referral to paediatrics, neurology, physiotherapy and developmental services can improve access to support. This is especially important when families must travel from rural areas or coordinate appointments through several state-based health systems.

Building A Safer Perinatal Plan

Prevention of perinatal stroke is a shared clinical responsibility rather than a single test or intervention. The most useful approach combines preconception counselling, reliable antenatal surveillance, treatment of maternal disease, attention to placental warning signs and a prepared neonatal response. It also recognises that many cases remain unexplained, so families should receive honest information without blame.

Australian services can strengthen this work by linking general practice with maternity units, pathology providers, pharmacists, retrieval networks and neonatal follow-up programs. A written plan should travel with the patient when care moves between a community clinic and a tertiary hospital. Digital records, interpreter access and telehealth can reduce gaps, but they should complement—not replace—urgent face-to-face assessment when symptoms are severe.

Clinicians and maternity organisations should review local protocols for hypertension, thrombosis, infection, fetal growth restriction and newborn neurological assessment. Families planning pregnancy can book a preconception appointment, disclose relevant medical and family history, take prescribed supplements, avoid tobacco and alcohol, and seek immediate care for bleeding, severe headache, reduced fetal movements or sudden neurological symptoms. Acting early turns recognised maternal risk into a clearer, safer pathway for parent and baby.